We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 2 of 38 for:    deep brain stimulation OCD

Deep Brain Stimulation for Severe Obsessive Compulsive Disorder

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT02655926
First Posted: January 14, 2016
Last Update Posted: March 3, 2017
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by (Responsible Party):
University College, London
  Purpose
The overarching aim is to compare the effects of ventral capsule/ventral striatum (VC/VS) and subthalamic nucleus (STN) deep brain stimulation (DBS) in the same participants. Investigators will test the hypothesis, grounded in cognitive neuroscience, that DBS at both sites is better than either site alone for treating the symptom dimensions of obsessive compulsive disorder (OCD). Specifically, Investigators will employ novel cognitive paradigms and neurophysiological measures of cortical synaptic function to test the hypothesis that VS/VC and STN DBS have different mechanisms of action and that alleviation of OCD symptoms is mediated by improvement in mood/anxiety with VS/VC DBS and by directly interrupting obsessions and compulsions with STN DBS. Investigators will additionally determine whether adjunctive cognitive behavioural therapy (CBT) enhances the response to DBS by providing the cognitive and behavioural skills to optimise symptom management and daily function.

Condition Intervention
Obsessive-Compulsive Disorder Procedure: Deep Brain Stimulation

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Crossover Assignment
Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
Primary Purpose: Treatment
Official Title: Deep Brain Stimulation for Severe Obsessive Compulsive Disorder: Efficacy and Mechanisms of Ventral Striatum and Subthalamic Nucleus Targets

Resource links provided by NLM:


Further study details as provided by University College, London:

Primary Outcome Measures:
  • Improvement of OCD symptoms on YBOCS scale greater than or equal to 35% [ Time Frame: 15 months ]

Enrollment: 6
Study Start Date: September 2012
Study Completion Date: November 2016
Primary Completion Date: November 2016 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Active Comparator: STN Arm
Participants would only have STN deep brain stimulation switched at optimal settings for that participant on for 12 weeks.
Procedure: Deep Brain Stimulation
Participants undergo implantation of bilateral electrodes at both the VS/VC and STN sites through a single burr hole under general anaesthesia. High-resolution MRI scans are used to calculate target coordinates and to verify accurate electrode location post-surgery. Each STN electrode have 4 electrical contacts at its distal tip (with a 0.5mm separation) and each VS/VC electrode have 4 electrical contacts at its distal tip (with a 1.5mm separation) to allow fine tuning of the exact site for stimulation delivery. Two non-rechargeable batteries (Activa PC) are connected to the electrodes and positioned under the skin of the right and left chest wall so that they correspond to the same set of electrodes for each patient: one for the 2 STN electrodes and one for the 2 VC/VS electrodes.
Other Name: DBS
Active Comparator: VC/VS Arm
Participants would only have VC/VS deep brain stimulation switched on at optimal settings for that participant for 12 weeks.
Procedure: Deep Brain Stimulation
Participants undergo implantation of bilateral electrodes at both the VS/VC and STN sites through a single burr hole under general anaesthesia. High-resolution MRI scans are used to calculate target coordinates and to verify accurate electrode location post-surgery. Each STN electrode have 4 electrical contacts at its distal tip (with a 0.5mm separation) and each VS/VC electrode have 4 electrical contacts at its distal tip (with a 1.5mm separation) to allow fine tuning of the exact site for stimulation delivery. Two non-rechargeable batteries (Activa PC) are connected to the electrodes and positioned under the skin of the right and left chest wall so that they correspond to the same set of electrodes for each patient: one for the 2 STN electrodes and one for the 2 VC/VS electrodes.
Other Name: DBS

  Show Detailed Description

  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   20 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  1. Participants must have undergone intensive treatment and have demonstrable treatment resistance as defined by:

    1. At least two serotonin reuptake inhibitors (SRI) for a minimum of 12 weeks at optimal British National Formulary (BNF) doses.
    2. Augmentation of SRI treatment with antipsychotic drugs administered at maximally tolerated doses or by extending the selective serotonin reuptake inhibitor (SSRI) dose beyond BNF limits.
    3. Two trials of CBT of at least 10 hours.
    4. Failed inpatient treatment for OCD.
  2. Participants must be older than 20 years of age.
  3. Confirmation of a primary diagnosis of obsessive compulsive disorder (International Classification of Diseases (ICD 10) F42.0—F42.9).
  4. Duration of OCD of at least 10 years.
  5. At least 2 years of unremitting symptoms despite intensive psychopharmacological and psychological treatment or failure to sustain, over a 3 month period, a response to inpatient psychological treatment by at least 33% with accompanying optimised pharmacological therapy.
  6. A minimum score of 32 on Yale Brown Obsessive Compulsive Scale (YBOCS) thus constituting profound illness and a maximum score of 50 on the Diagnostic and Statistical Manual of Mental Disorders (DSM IV) General Assessment of Function Scale (GAF).
  7. Ability to provide sustained informed consent.

Exclusion Criteria:

  1. Current diagnosis of Substance misuse (ICD10 F10—F19)
  2. Current diagnosis of Organic brain syndrome (ICD10 F00—F09)
  3. Current diagnosis of Adult personality disorder (ICD10 F60—F69)
  4. Current diagnosis of Pervasive developmental disorder (ICD10 F84)
  5. Current diagnosis of Schizophrenia (ICD10 F20-F29)
  6. Current diagnosis of Bipolar disorder (ICD 10 F30-31)
  7. Contraindications to neurosurgery
  8. Pregnancy
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02655926


Locations
United Kingdom
UCL Institute of Neurology
London, United Kingdom, WC1N 3BG
Sponsors and Collaborators
University College, London
Investigators
Principal Investigator: Eileen M Joyce, PhD University College, London
  More Information

Publications:

Responsible Party: University College, London
ClinicalTrials.gov Identifier: NCT02655926     History of Changes
Other Study ID Numbers: 12/0226
MR/J012009/1 ( Other Grant/Funding Number: Medical Research Council (MRC), UK )
12/LO/1087 ( Other Identifier: Research Ethics Committee (REC), Stanmore )
105869 ( Other Identifier: Integrated Research Approval System (IRAS) Protocol Ref )
18430630 ( Registry Identifier: International Standard RCT Number (ISRCTN) )
First Submitted: July 17, 2015
First Posted: January 14, 2016
Last Update Posted: March 3, 2017
Last Verified: July 2015

Keywords provided by University College, London:
OCD
DBS
Deep Brain Stimulation

Additional relevant MeSH terms:
Disease
Compulsive Personality Disorder
Obsessive-Compulsive Disorder
Pathologic Processes
Personality Disorders
Mental Disorders
Anxiety Disorders